NEW YORK (GenomeWeb News) – Eastern Biotech and Life Sciences, Dubai and BGI Health have partnered to make available to parts of the Middle East a non-invasive prenatal diagnostic test for detecting trisomy 21.

Eastern Biotech launched the test called Trigene on Thursday, and it and BGI Health are also making the next-generation sequencing-based test available in the United Arab Emirates and other countries that are part of the Cooperation Council for the Arab States of the Gulf, Eastern Biotech said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.